1. Inflammatory mediators produced by the ocular surface after mycotoxin exposure impact the nasal epithelium. (10th October 2016) Authors: Achard, S.; Bossou, M.; Serssar, Y.; Menotti, J.; Momas, I.; Seta, N. Journal: Toxicology letters Issue: Volume 259(2016)Supplement Page Start: S239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Airway epithelium co-cultured with immune cells to assess the impact of air pollutants on the inflammatory response. (10th October 2016) Authors: Achard, S.; Ricquebourg, E.; Momas, I.; Seta, N. Journal: Toxicology letters Issue: Volume 259(2016)Supplement Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0468 The Unique Subset of Monocytes Expressing CD14bright and CD16 is Increased with Disease Activity and Changed with Treatment Response in Patients with Rheumatoid Arthritis. (10th June 2014) Authors: Tsukamoto, M.; Yoshimoto, K.; Seta, N.; Suzuki, K.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 962 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0431 Clinical Evaluation of Treat-to-Target Strategy-Based Management Using Shortening Interval Methods for Infliximab in Patients with Rheumatoid Arthritis. (9th June 2015) Authors: Kurasawa, T.; Suzuki, K.; Hanaoka, H.; Kaneko, Y.; Yasuoka, H.; Seta, N.; Yamaoka, K.; Kameda, H.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0544 Efficacy and safety of tocilizumab in patients with rheumatoid arthritis in the presence or absence of previous treatment with biologics and concomitant treatment with methotrexate. (23rd January 2014) Authors: Izumi, K.; Kaneko, Y.; Yasuoka, H.; Seta, N.; Kameda, H.; Kuwana, M.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0319 Treatment with tocilizumab improved rheumatoid arthritis patients clinically and structurally regardless of the prior use of anti-tnf biologics in daily clinical practice. (23rd January 2014) Authors: Izumi, K.; Kaneko, Y.; Yasuoka, H.; Seta, N.; Kameda, H.; Kuwana, M.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Airway epithelium co-cultured with immune cells for a better assessment of the low dose effects of environmental pollutants on the inflammatory response. (16th October 2015) Authors: Ricquebourg, E.; Achard, S.; Bardet, G.; Seta, N.; Momas, I. Journal: Toxicology letters Issue: Volume 238(2015)Supplement Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity. Issue 1 (December 2016) Authors: Sabry, S.; Vuillaumier-Barrot, S.; Mintet, E.; Fasseu, M.; Valayannopoulos, V.; Héron, D.; Dorison, N.; Mignot, C.; Seta, N.; Chantret, I.; Dupré, T.; Moore, S. Journal: Orphanet journal of rare diseases Issue: Volume 11:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗